7P7-33810-28158
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 800 / CO
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-14
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
-
2021-04-15
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Heart rate increased — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: increased heart rate, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-16
-
2021-04-17
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Itching on backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
-
2021-05-05
Dose 2 — Pfizer-BioNTech
- 2021-05-05
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-07
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-21
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-08-04
- 2021-11-03
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
-
2021-12-25
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Fair · Site: Redness · Fatigue or tirednessFree text: Increased heart rateMedDRA releases: 2024-11 · check-in free text available
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-03-25
- 2022-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Pfizer-BioNTech | |
| 2 | 2021-05-05 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-15 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): increased heart rate, shortness of breath
Systemic reaction (other): Itching on back
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Increased heart rate
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release